Antibody response to the chlamydial heat-shock protein 60 in an experimental model of chronic pelvic inflammatory disease in monkeys (Macaca nemestrina)

被引:30
作者
Peeling, RW
Patton, DL
Sweeney, YTC
Cheang, MS
Lichtenwalner, AB
Brunham, RC
Stamm, WE
机构
[1] Lab Ctr Dis Control, Natl Lab STDs, Winnipeg, MB R3E 3R2, Canada
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[4] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[6] Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA
[7] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA USA
关键词
D O I
10.1086/314919
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A primate model of chlamydial pelvic inflammatory disease was used to characterize serum antibody responses to the 60 kDa chlamydial heat shock protein (CHSP60). Forty monkeys were infected in the fallopian tubes with Chlamydia trachomatis and then were treated, Twenty-three (58%) monkeys developed antibodies against CHSP60, of whom 6 (15%) had CHSP60 responses that persisted throughout the study and 17 (42.5%) had a transient response. A persistent CHSP60 antibody response was correlated with being culture- or ligase chain reaction-positive in the fallopian tubes (P =.004), but not in the cervix pretreatment, and with being tubal-positive posttreatment (P =.02). Compared with tubal-negative monkeys, tubal-positive monkeys had more intense CHSP60 responses (P =.006) that lasted longer (P =.002). Among CHSP60 responders, an OD > 0.5 was correlated with more severe salpingeal pathology before treatment (P =.04), CHSP60 antibody response may be useful as a marker of persistent chlamydial infection in the fallopian tubes.
引用
收藏
页码:774 / 779
页数:6
相关论文
共 27 条
[1]  
Armitage P., 1971, STAT METHODS MED RES
[2]   IMMUNOELECTRONMICROSCOPIC QUANTITATION OF DIFFERENTIAL LEVELS OF CHLAMYDIAL PROTEINS IN A CELL-CULTURE MODEL OF PERSISTENT CHLAMYDIA-TRACHOMATIS INFECTION [J].
BEATTY, WL ;
MORRISON, RP ;
BYRNE, GI .
INFECTION AND IMMUNITY, 1994, 62 (09) :4059-4062
[3]  
BRUNHAM RC, 1994, INFECT AGENT DIS, V3, P218
[4]   GENITAL CHLAMYDIAL INFECTIONS - EPIDEMIOLOGY AND REPRODUCTIVE SEQUELAE [J].
CATES, W ;
WASSERHEIT, JN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (06) :1771-1781
[5]   The presence of serum antibody to the chlamydial heat shock protein (CHSP60) as a diagnostic test for tubal factor infertility [J].
Claman, P ;
Honey, L ;
Peeling, RW ;
Jessamine, P ;
Toye, B .
FERTILITY AND STERILITY, 1997, 67 (03) :501-504
[6]   HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis endemic population [J].
Conway, DJ ;
Holland, MJ ;
Campbell, AE ;
Bailey, RL ;
Krausa, P ;
Peeling, RW ;
Whittle, HC ;
Mabey, DCW .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (03) :643-646
[7]   Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease [J].
Domeika, M ;
Domeika, K ;
Paavonen, J ;
Mårdh, PA ;
Witkin, SS .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :714-719
[8]   Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease [J].
Eckert, LO ;
Hawes, SE ;
WolnerHanssen, P ;
Money, DM ;
Peeling, RW ;
Brunham, RC ;
Stevens, CE ;
Eschenbach, DA ;
Stamm, WE .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1453-1458
[9]   CONJUNCTIVAL SCARRING IN TRACHOMA IS ASSOCIATED WITH DEPRESSED CELL-MEDIATED IMMUNE-RESPONSES TO CHLAMYDIAL ANTIGENS [J].
HOLLAND, MJ ;
BAILEY, RL ;
HAYES, LJ ;
WHITTLE, HC ;
MABEY, DCW .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1528-1531
[10]   Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya [J].
Kimani, J ;
Maclean, IW ;
Bwayo, JJ ;
MacDonald, K ;
Oyugi, J ;
Maitha, GM ;
Peeling, RW ;
Cheang, M ;
Nagelkerke, NJD ;
Plummer, FA ;
Brunham, RC .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1437-1444